Cyclophosphamide Injection
Product Images NDC 83831-118

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Cyclophosphamide (NDC 83831-118). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avyxa Pharma, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (702d4e46 776d 42d1 A560 02684bbe8ac6 01)

Chemical structure of cyclophosphamide, showing its ring structure with phosphorus, oxygen, nitrogen atoms, and the attached 2-(2-chloroethyl) groups along with one water molecule (hydrate).*

FDA Label Image

Cyclophosphamide Injection, 500 mg/ml -vial Label (702d4e46 776d 42d1 A560 02684bbe8ac6 02)

Label for Cyclophosphamide Injection 500 mg/mL single-dose vial, manufactured for Avyxa Pharma, LLC. The label includes storage instructions (refrigerate at 2°C to 8°C) and cautions about diluting with specific solutions before intravenous use. It also notes the product is a hazardous drug and prescription only.*

FDA Label Image

Cyclophosphamide Injection, 500 mg/ml -carton Label (702d4e46 776d 42d1 A560 02684bbe8ac6 03)

Cyclophosphamide Injection 500 mg/mL in a single-dose vial label. The label indicates the product is a hazardous drug, sterile, and for intravenous use only, with instructions to dilute before administration. Manufactured for Avyxa Pharma, LLC. Storage instructions specify refrigeration at 2°C to 8°C (36°F to 46°F). The label includes caution information about dilution and a barcode.*

FDA Label Image

Cyclophosphamide Injection, 1 G/2 mL (Vial Label)

Cyclophosphamide Injection 1 gram/2 mL (500 mg/mL) single-dose vial label. It states that the vial must be diluted before intravenous use and unused portions should be discarded. The label indicates it is a hazardous drug, Rx only, and includes storage instructions to refrigerate vials at 2°C to 8°C (36°F to 46°F). Manufactured for Avyxa Pharma, LLC, New Jersey, USA, made in India.*

FDA Label Image

Cyclophosphamide Injection, 1 G/2 mL (Carton Label)

Cyclophosphamide Injection 1 gram/2 mL (500 mg/mL) vial label by Avyxa Pharma, LLC. The label states it must be diluted before intravenous use, is a single-dose vial, and a hazardous drug. Storage instructions specify refrigeration at 2°C to 8°C. Warnings include use of specific diluents. Manufactured for Avyxa Pharma, New Jersey, made in India.*

FDA Label Image

Cyclophosphamide Injection, 2 G/4 mL (Vial Label)

Cyclophosphamide Injection 2 gram/4 mL (500 mg/mL) in a single-dose vial. The label indicates it is a hazardous drug for intravenous use, requiring dilution before administration. Manufactured for Avyxa Pharma, LLC, with storage instructions between 2°C and 8°C (36°F to 46°F). Made in India.*

FDA Label Image

Cyclophosphamide Injection, 2 G/4 mL (Carton Label)

Cyclophosphamide Injection 2 gram/4 mL (500 mg/mL) vial label by Avyxa Pharma, LLC. The label states it is a sterile, hazardous drug requiring dilution before intravenous use. It includes storage instructions and cautions for dilution solutions. Manufactured for Avyxa Pharma, LLC, New Jersey, made in India, with NDC 83831-118-04 and J Code J9072.*

FDA Label Image

Image (702d4e46 776d 42d1 A560 02684bbe8ac6 126 1)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.